Skip to content

Entecavir

Entecavir (Baraclude) is an antiviral medicine used in the treatment of chronic hepatitis B. This page covers the one formulation listed in the catalogue.

Baraclude

Chronic Hepatitis B

0.5mg · 1mg

Entecavir tablets for chronic hepatitis B. It mimics a building block the virus needs, stopping it from copying itself.

From$5.74/ tabletView

Key points

  • How it works: Entecavir stops the hepatitis B virus from copying itself inside liver cells, which helps reduce the amount of virus in the body.
  • Two strengths: The tablet comes in 0.5mg and 1mg doses, with the lower strength used for most adults who have not previously taken antiviral medicine.
  • Originator brand: Baraclude was first developed by Bristol-Myers Squibb and is the only product listed in this catalogue.

Common questions about Entecavir

What is the difference between the 0.5mg and 1mg tablets?

The 0.5mg tablet is typically prescribed for adults who have not previously taken antiviral treatment for hepatitis B, while the 1mg dose is used for those who have been on treatment or have a higher viral load. A doctor will decide which strength is right based on individual needs.

Does entecavir clear hepatitis B from the body?

Entecavir does not clear the virus, but it can lower the amount of virus in the body and help protect the liver. Treatment is usually long term, and stopping it should only be done under medical guidance.

Further reading